20828565|t|An aminopeptidase from Streptomyces sp. KK565 degrades beta amyloid monomers, oligomers and fibrils.
20828565|a|The accumulation of beta amyloid (Abeta) has been a primary target for Alzheimer disease therapeutic strategies. Previously, we discovered an activity from Streptomyces sp. KK565 growth media that inhibits Abeta aggregation. The active component was an aminopeptidase and named Streptomyces sp. KK565 aminopeptidase (SKAP). SKAP cleaved N-terminal amino-acids of Abeta(1-42) monomer, inhibited formation of fibrils and protected Abeta(1-42)-induced neurotoxicity. Over-expression of a human homolog of SKAP, glutamate carboxypeptidase II (hGCPII) in Abeta-oversynthesizing cells dramatically reduced the Abeta levels. These findings suggest a possible role of M28 family peptidases in preventing Abeta deposits in mammalian brain.
20828565	3	17	aminopeptidase	Gene	10404
20828565	23	39	Streptomyces sp.	Species	1931
20828565	135	140	Abeta	Gene	351
20828565	172	189	Alzheimer disease	Disease	MESH:D000544
20828565	257	273	Streptomyces sp.	Species	1931
20828565	274	292	KK565 growth media	Chemical	-
20828565	307	312	Abeta	Gene	351
20828565	354	368	aminopeptidase	Gene	10404
20828565	379	395	Streptomyces sp.	Species	1931
20828565	550	563	neurotoxicity	Disease	MESH:D020258
20828565	586	591	human	Species	9606
20828565	609	638	glutamate carboxypeptidase II	Gene	2346
20828565	651	656	Abeta	Gene	351
20828565	705	710	Abeta	Gene	351
20828565	797	802	Abeta	Gene	351
20828565	Association	MESH:D000544	351
20828565	Negative_Correlation	2346	351

